Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-01-24 5:11 pm Unchanged | 13D | GYRE THERAPEUTICS INC GYRE | GNI Group Ltd. | 73,313,885 85.34% | 0 (Unchanged) | View |
| 2023-11-27 4:49 pm Unchanged | 13D | GYRE THERAPEUTICS INC GYRE | GNI Group Ltd. | 73,313,885 85.36% | 0 (Unchanged) | View |
| 2023-11-01 4:58 pm Purchase | 13D | GYRE THERAPEUTICS INC GYRE | GNI Group Ltd. | 73,313,885 85.36% | 73,313,885 (New Position) | View |
| 2023-10-30 7:28 pm Unchanged | 13D | CATALYST BIOSCIENCES INC N CBIO | GNI Group Ltd. | 6,266,521 16.5% | 0 (Unchanged) | View |
| 2023-01-04 6:13 pm Purchase | 13D | CATALYST BIOSCIENCES INC N CBIO | GNI Group Ltd. | 6,266,521 16.6% | 6,266,521 (New Position) | View |